MeridianConsensus
Operator profileFranceData as of June 2026

bioMérieux

bioMérieux is French company specialised in in vitro diagnostics. Founded in 1963. (Wikidata)

bioMérieux's strongest tracked position is the Pet Pathogen Detection Kits Market at an estimated 3.4% share in a market growing at 6.8% CAGR. Average estimated share across all tracked markets is 4.2%, indicating a meaningful incumbent presence.

Meridian Consensus tracks bioMérieux in 2 markets across 2 industries (healthcare, Healthcare). Estimated in-market revenue is $153M, the sum of share × market size across appearances — a modeled figure, not reported company revenue.

Markets tracked
2
Industries
2
Est. in-market revenue
$153M
Top market share
3.4%

Share and revenue figures are Meridian model estimates reconciled through the publish-gate validator, not audited financials. Methodology

Market positions

Avg share 4.2% · sorted by est. revenue
MarketCAGRShare
Pet Pathogen Detection Kits Market6.8%3.4%
Veterinary Urinalysis Market5.0%5.0%
Est. revenue by market (share × market size)
Pet Pathogen Detection Kits$98M
Veterinary Urinalysis$55M

Meridian Dossier

Need diligence-grade depth on bioMérieux?

Commission a source-cited diligence dossier on bioMérieux: identity, filed financials, IP, litigation, and government exposure. Free preview first, from $299.

bioMérieux: frequently asked

Meridian Consensus tracks bioMérieux in 2 markets: Pet Pathogen Detection Kits Market ($2.9B), Veterinary Urinalysis Market ($1.1B), spanning healthcare, Healthcare.

bioMérieux's strongest tracked position is the Pet Pathogen Detection Kits Market, a $2.9B market growing at 6.8% CAGR, where it holds an estimated 3.4% share as of June 2026.

Across Meridian-tracked markets, bioMérieux's closest peers are IDEXX Laboratories, Zoetis, Antech Diagnostics, Virbac, Neogen Corporation, with the largest overlap in the Pet Pathogen Detection Kits Market. Peer mapping is based on co-appearance in the same tracked markets.

No. Share and revenue figures on this page are model estimates produced by Meridian's research pipeline and committee-reviewed before publication; they are not audited or exchange-filed financials. Market-level sizings are reconciled against external sources during the publish gate.

Adjacent markets in healthcare · Healthcare

Tracked markets in the same industries where bioMérieux is not among the named operators. Each carries Porter Five Forces, SWOT, country analysis, and a full competitor table.

Operators that compete with bioMérieux

Meridian Consensus Digest

Free · Weekly

Not ready to commission a full report? Get our weekly briefing instead: new market sizings, thesis revisions, and reconciliation updates. Signed by the research team. No sales emails.

Subscribed by teams in Corporate Development, PE, and Management Consulting. Unsubscribe in one click.